COMBINED ANTICANCER DRUG SENSITIVITY-DETERMINING MARKER
Provided are an anticancer sensitivity-determining marker by which responsiveness to treatment of individual patients can be discriminated and a novel cancer treatment means using the same. A marker for determining the sensitivity to an anticancer drug including oxaliplatin or a salt thereof and flu...
Gespeichert in:
Hauptverfasser: | , , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre ; jpn |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!